Related Articles
shRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib
HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells
IQGAP1 plays an important role in the cell proliferation of multiple myeloma via the MAP kinase (ERK) pathway
Cyclooxygenase-2 inhibitor and interferon-β synergistically induce apoptosis in human hepatoma cells in vitro and in vivo